Structure

Physi-Chem Properties

Molecular Weight:  286.08
Volume:  279.199
LogP:  2.698
LogD:  2.553
LogS:  -3.873
# Rotatable Bonds:  1
TPSA:  68.15
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.789
Synthetic Accessibility Score:  3.355
Fsp3:  0.25
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.923
MDCK Permeability:  1.185413020721171e-05
Pgp-inhibitor:  0.096
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.003

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.04
Plasma Protein Binding (PPB):  98.87848663330078%
Volume Distribution (VD):  0.506
Pgp-substrate:  3.843402147293091%

ADMET: Metabolism

CYP1A2-inhibitor:  0.905
CYP1A2-substrate:  0.932
CYP2C19-inhibitor:  0.751
CYP2C19-substrate:  0.564
CYP2C9-inhibitor:  0.842
CYP2C9-substrate:  0.895
CYP2D6-inhibitor:  0.615
CYP2D6-substrate:  0.871
CYP3A4-inhibitor:  0.496
CYP3A4-substrate:  0.534

ADMET: Excretion

Clearance (CL):  5.146
Half-life (T1/2):  0.447

ADMET: Toxicity

hERG Blockers:  0.052
Human Hepatotoxicity (H-HT):  0.714
Drug-inuced Liver Injury (DILI):  0.886
AMES Toxicity:  0.889
Rat Oral Acute Toxicity:  0.309
Maximum Recommended Daily Dose:  0.825
Skin Sensitization:  0.921
Carcinogencity:  0.585
Eye Corrosion:  0.003
Eye Irritation:  0.864
Respiratory Toxicity:  0.553

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC232164

Natural Product ID:  NPC232164
Common Name*:   4-Hydroxymedicarpin
IUPAC Name:   (6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromene-3,4-diol
Synonyms:   4-Hydroxymedicarpin
Standard InCHIKey:  YRFDJOAWSXSLMG-NHYWBVRUSA-N
Standard InCHI:  InChI=1S/C16H14O5/c1-19-8-2-3-9-11-7-20-16-10(4-5-12(17)14(16)18)15(11)21-13(9)6-8/h2-6,11,15,17-18H,7H2,1H3/t11-,15-/m0/s1
SMILES:  COc1ccc2c(c1)O[C@@H]1[C@H]2COc2c1ccc(c2O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL253466
PubChem CID:   13940834
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0002617] Furanoisoflavonoids
          • [CHEMONTID:0001608] Pterocarpans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29804 Nepalese propolis n.a. n.a. n.a. n.a. n.a. n.a. PMID[15974608]
NPO33288 Brazilian Red Propolis Strain n.a. n.a. n.a. Brazilian n.a. PMID[17950610]
NPO33288 Brazilian Red Propolis Strain n.a. n.a. n.a. Brazilian n.a. PMID[18440233]
NPO33288 Brazilian Red Propolis Strain n.a. n.a. n.a. n.a. n.a. PMID[26938776]
NPO33288 Brazilian Red Propolis Strain n.a. n.a. n.a. n.a. n.a. PMID[32525315]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT461 Cell Line PANC-1 Homo sapiens CD100 = 25.0 uM PMID[497612]
NPT81 Cell Line A549 Homo sapiens IC50 > 100000.0 nM PMID[497613]
NPT165 Cell Line HeLa Homo sapiens IC50 > 100000.0 nM PMID[497613]
NPT453 Cell Line HT-1080 Homo sapiens IC50 > 100000.0 nM PMID[497613]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 100000.0 nM PMID[497613]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 54100.0 nM PMID[497613]
NPT20763 CELL-LINE J774.1 Mus musculus IC50 = 5400.0 nM PMID[497614]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC232164 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC473739
1.0 High Similarity NPC236306
0.9924 High Similarity NPC309124
0.9924 High Similarity NPC184797
0.9776 High Similarity NPC107161
0.9701 High Similarity NPC247291
0.9697 High Similarity NPC248727
0.9697 High Similarity NPC270456
0.9697 High Similarity NPC162659
0.9697 High Similarity NPC265433
0.9632 High Similarity NPC280092
0.9632 High Similarity NPC93323
0.9632 High Similarity NPC12641
0.9632 High Similarity NPC45257
0.9627 High Similarity NPC254759
0.9627 High Similarity NPC160283
0.9627 High Similarity NPC27495
0.9621 High Similarity NPC112939
0.9621 High Similarity NPC474206
0.9621 High Similarity NPC112246
0.9621 High Similarity NPC121812
0.9621 High Similarity NPC470356
0.9621 High Similarity NPC94750
0.9559 High Similarity NPC85264
0.9559 High Similarity NPC102044
0.9559 High Similarity NPC47633
0.9556 High Similarity NPC263261
0.9556 High Similarity NPC471389
0.9556 High Similarity NPC87725
0.9552 High Similarity NPC319647
0.9552 High Similarity NPC70682
0.9552 High Similarity NPC245207
0.9552 High Similarity NPC292882
0.9552 High Similarity NPC25966
0.9552 High Similarity NPC127218
0.9552 High Similarity NPC260741
0.9549 High Similarity NPC306441
0.9549 High Similarity NPC230734
0.9549 High Similarity NPC474639
0.9549 High Similarity NPC227503
0.9549 High Similarity NPC16435
0.9545 High Similarity NPC317380
0.9542 High Similarity NPC202762
0.9542 High Similarity NPC86655
0.9489 High Similarity NPC63879
0.9478 High Similarity NPC474282
0.9478 High Similarity NPC176051
0.9478 High Similarity NPC103976
0.9478 High Similarity NPC102904
0.9478 High Similarity NPC107551
0.9478 High Similarity NPC276490
0.9478 High Similarity NPC326797
0.9478 High Similarity NPC211549
0.9474 High Similarity NPC47398
0.9474 High Similarity NPC151224
0.9474 High Similarity NPC61946
0.9474 High Similarity NPC260898
0.9474 High Similarity NPC234333
0.947 High Similarity NPC158331
0.947 High Similarity NPC11060
0.9424 High Similarity NPC16269
0.9424 High Similarity NPC21776
0.9416 High Similarity NPC81638
0.9416 High Similarity NPC477616
0.9412 High Similarity NPC35216
0.9412 High Similarity NPC311530
0.9407 High Similarity NPC471388
0.9403 High Similarity NPC234952
0.9403 High Similarity NPC302701
0.9403 High Similarity NPC269091
0.9403 High Similarity NPC173660
0.9398 High Similarity NPC478085
0.9398 High Similarity NPC287745
0.9394 High Similarity NPC126029
0.9394 High Similarity NPC261619
0.9394 High Similarity NPC185604
0.9394 High Similarity NPC61477
0.9394 High Similarity NPC78770
0.9394 High Similarity NPC127624
0.9394 High Similarity NPC219876
0.9394 High Similarity NPC15658
0.9394 High Similarity NPC175067
0.9394 High Similarity NPC204215
0.9357 High Similarity NPC166584
0.9357 High Similarity NPC301961
0.9353 High Similarity NPC317053
0.9353 High Similarity NPC324492
0.9353 High Similarity NPC260397
0.9348 High Similarity NPC473108
0.9343 High Similarity NPC2613
0.9343 High Similarity NPC475891
0.9343 High Similarity NPC59841
0.9343 High Similarity NPC204347
0.9338 High Similarity NPC259519
0.9333 High Similarity NPC477938
0.9328 High Similarity NPC164787
0.9328 High Similarity NPC126409
0.9328 High Similarity NPC473413
0.9328 High Similarity NPC134968
0.9328 High Similarity NPC99572
0.9328 High Similarity NPC195022
0.9323 High Similarity NPC475840
0.9323 High Similarity NPC263064
0.9323 High Similarity NPC229442
0.9323 High Similarity NPC168059
0.9318 High Similarity NPC268342
0.9318 High Similarity NPC220825
0.9318 High Similarity NPC42760
0.9318 High Similarity NPC268266
0.9286 High Similarity NPC320970
0.9286 High Similarity NPC328567
0.9286 High Similarity NPC101376
0.9286 High Similarity NPC320671
0.9286 High Similarity NPC327412
0.9281 High Similarity NPC469557
0.9281 High Similarity NPC307466
0.927 High Similarity NPC178054
0.9265 High Similarity NPC292487
0.9265 High Similarity NPC32630
0.9259 High Similarity NPC472334
0.9259 High Similarity NPC477939
0.9259 High Similarity NPC177160
0.9259 High Similarity NPC54743
0.9259 High Similarity NPC209985
0.9259 High Similarity NPC156502
0.9259 High Similarity NPC10737
0.9259 High Similarity NPC472336
0.9259 High Similarity NPC470802
0.9259 High Similarity NPC263367
0.9259 High Similarity NPC29799
0.9254 High Similarity NPC49603
0.9254 High Similarity NPC244983
0.9254 High Similarity NPC474478
0.9254 High Similarity NPC193026
0.9254 High Similarity NPC187616
0.9254 High Similarity NPC170694
0.9254 High Similarity NPC326095
0.9254 High Similarity NPC106215
0.9248 High Similarity NPC201587
0.9248 High Similarity NPC253105
0.9242 High Similarity NPC91291
0.9237 High Similarity NPC226331
0.9237 High Similarity NPC47283
0.9237 High Similarity NPC46274
0.9237 High Similarity NPC39064
0.9214 High Similarity NPC226540
0.9214 High Similarity NPC87794
0.9214 High Similarity NPC211758
0.9209 High Similarity NPC50250
0.9209 High Similarity NPC114119
0.9209 High Similarity NPC317237
0.9209 High Similarity NPC471415
0.9209 High Similarity NPC470097
0.9209 High Similarity NPC277951
0.9209 High Similarity NPC44530
0.9197 High Similarity NPC22317
0.9197 High Similarity NPC266197
0.9197 High Similarity NPC291101
0.9191 High Similarity NPC94994
0.9185 High Similarity NPC472337
0.9185 High Similarity NPC24490
0.9185 High Similarity NPC34103
0.9185 High Similarity NPC141765
0.9185 High Similarity NPC165155
0.9173 High Similarity NPC472597
0.9173 High Similarity NPC474017
0.9173 High Similarity NPC162801
0.916 High Similarity NPC250432
0.916 High Similarity NPC5447
0.9149 High Similarity NPC39657
0.9143 High Similarity NPC11422
0.9143 High Similarity NPC474749
0.9143 High Similarity NPC181615
0.9143 High Similarity NPC178014
0.9143 High Similarity NPC42716
0.9137 High Similarity NPC163508
0.9137 High Similarity NPC135767
0.9137 High Similarity NPC155392
0.9137 High Similarity NPC173203
0.9137 High Similarity NPC274721
0.913 High Similarity NPC265075
0.9124 High Similarity NPC22517
0.9118 High Similarity NPC78047
0.9111 High Similarity NPC117048
0.9111 High Similarity NPC124085
0.9104 High Similarity NPC16208
0.9104 High Similarity NPC35932
0.9104 High Similarity NPC470752
0.9104 High Similarity NPC6451
0.9104 High Similarity NPC160991
0.9104 High Similarity NPC7903
0.9104 High Similarity NPC184447
0.9098 High Similarity NPC145305
0.9098 High Similarity NPC42300
0.9098 High Similarity NPC92164
0.9098 High Similarity NPC241522
0.9098 High Similarity NPC242807
0.9098 High Similarity NPC472338
0.9098 High Similarity NPC257582
0.9098 High Similarity NPC187998

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC232164 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9394 High Similarity NPD1613 Approved
0.9394 High Similarity NPD1612 Clinical (unspecified phase)
0.9237 High Similarity NPD1529 Clinical (unspecified phase)
0.916 High Similarity NPD1530 Clinical (unspecified phase)
0.9023 High Similarity NPD3027 Phase 3
0.8702 High Similarity NPD1610 Phase 2
0.8667 High Similarity NPD4908 Phase 1
0.854 High Similarity NPD4907 Clinical (unspecified phase)
0.8523 High Similarity NPD1934 Approved
0.8456 Intermediate Similarity NPD2861 Phase 2
0.8258 Intermediate Similarity NPD1548 Phase 1
0.8224 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8162 Intermediate Similarity NPD4749 Approved
0.8129 Intermediate Similarity NPD6234 Discontinued
0.8071 Intermediate Similarity NPD4625 Phase 3
0.8014 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.8013 Intermediate Similarity NPD1653 Approved
0.8 Intermediate Similarity NPD3882 Suspended
0.8 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD6166 Phase 2
0.7987 Intermediate Similarity NPD2801 Approved
0.7987 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD3018 Phase 2
0.7922 Intermediate Similarity NPD37 Approved
0.7911 Intermediate Similarity NPD7199 Phase 2
0.7888 Intermediate Similarity NPD7228 Approved
0.7888 Intermediate Similarity NPD3818 Discontinued
0.7885 Intermediate Similarity NPD4967 Phase 2
0.7885 Intermediate Similarity NPD4965 Approved
0.7885 Intermediate Similarity NPD4966 Approved
0.7879 Intermediate Similarity NPD5283 Phase 1
0.7867 Intermediate Similarity NPD1511 Approved
0.7863 Intermediate Similarity NPD228 Approved
0.7848 Intermediate Similarity NPD5494 Approved
0.7838 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7838 Intermediate Similarity NPD6674 Discontinued
0.7812 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD7074 Phase 3
0.7778 Intermediate Similarity NPD4060 Phase 1
0.7778 Intermediate Similarity NPD3620 Phase 2
0.7778 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD2982 Phase 2
0.777 Intermediate Similarity NPD2983 Phase 2
0.7763 Intermediate Similarity NPD1512 Approved
0.773 Intermediate Similarity NPD7054 Approved
0.7698 Intermediate Similarity NPD2981 Phase 2
0.7683 Intermediate Similarity NPD7472 Approved
0.7655 Intermediate Similarity NPD1558 Phase 1
0.7643 Intermediate Similarity NPD1465 Phase 2
0.7626 Intermediate Similarity NPD1091 Approved
0.7626 Intermediate Similarity NPD3705 Approved
0.7622 Intermediate Similarity NPD5844 Phase 1
0.7595 Intermediate Similarity NPD3817 Phase 2
0.7584 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD3021 Approved
0.7576 Intermediate Similarity NPD3022 Approved
0.7568 Intermediate Similarity NPD5588 Approved
0.7533 Intermediate Similarity NPD1549 Phase 2
0.753 Intermediate Similarity NPD6797 Phase 2
0.7518 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD6099 Approved
0.7517 Intermediate Similarity NPD6100 Approved
0.7517 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD7213 Phase 3
0.7516 Intermediate Similarity NPD7212 Phase 2
0.75 Intermediate Similarity NPD4536 Approved
0.75 Intermediate Similarity NPD4538 Approved
0.75 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6671 Approved
0.75 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD422 Phase 1
0.75 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD7251 Discontinued
0.7484 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD5124 Phase 1
0.7483 Intermediate Similarity NPD1652 Phase 2
0.7483 Intermediate Similarity NPD6355 Discontinued
0.7483 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD5177 Phase 3
0.7468 Intermediate Similarity NPD7447 Phase 1
0.7467 Intermediate Similarity NPD7266 Discontinued
0.7465 Intermediate Similarity NPD8651 Approved
0.7452 Intermediate Similarity NPD4380 Phase 2
0.7452 Intermediate Similarity NPD4675 Approved
0.7452 Intermediate Similarity NPD4678 Approved
0.7451 Intermediate Similarity NPD5058 Phase 3
0.745 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.745 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD7549 Discontinued
0.744 Intermediate Similarity NPD7808 Phase 3
0.7439 Intermediate Similarity NPD27 Approved
0.7439 Intermediate Similarity NPD2489 Approved
0.7434 Intermediate Similarity NPD3892 Phase 2
0.7434 Intermediate Similarity NPD7466 Approved
0.7434 Intermediate Similarity NPD6331 Phase 2
0.7425 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7424 Intermediate Similarity NPD290 Approved
0.7419 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD4577 Approved
0.7396 Intermediate Similarity NPD7311 Approved
0.7396 Intermediate Similarity NPD7312 Approved
0.7396 Intermediate Similarity NPD7310 Approved
0.7396 Intermediate Similarity NPD4578 Approved
0.7396 Intermediate Similarity NPD7313 Approved
0.7394 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD7075 Discontinued
0.7391 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD6559 Discontinued
0.7381 Intermediate Similarity NPD7240 Approved
0.7378 Intermediate Similarity NPD2969 Approved
0.7378 Intermediate Similarity NPD2970 Approved
0.7375 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD7157 Approved
0.7368 Intermediate Similarity NPD4663 Approved
0.7368 Intermediate Similarity NPD2684 Approved
0.7365 Intermediate Similarity NPD5735 Approved
0.7355 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD8054 Approved
0.7353 Intermediate Similarity NPD8053 Approved
0.7353 Intermediate Similarity NPD7309 Approved
0.7351 Intermediate Similarity NPD5763 Approved
0.7351 Intermediate Similarity NPD5762 Approved
0.7351 Intermediate Similarity NPD3540 Phase 1
0.7333 Intermediate Similarity NPD5960 Phase 3
0.7326 Intermediate Similarity NPD7906 Approved
0.732 Intermediate Similarity NPD3750 Approved
0.732 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD4110 Phase 3
0.732 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD6232 Discontinued
0.7317 Intermediate Similarity NPD3051 Approved
0.7312 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.729 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD7473 Discontinued
0.7286 Intermediate Similarity NPD1357 Approved
0.7285 Intermediate Similarity NPD3539 Phase 1
0.7279 Intermediate Similarity NPD6798 Discontinued
0.7279 Intermediate Similarity NPD7843 Approved
0.7278 Intermediate Similarity NPD4005 Discontinued
0.7273 Intermediate Similarity NPD2677 Approved
0.7267 Intermediate Similarity NPD2560 Approved
0.7267 Intermediate Similarity NPD2563 Approved
0.7255 Intermediate Similarity NPD4236 Phase 3
0.7255 Intermediate Similarity NPD4237 Approved
0.7244 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD6584 Phase 3
0.7237 Intermediate Similarity NPD1375 Discontinued
0.7226 Intermediate Similarity NPD7124 Phase 2
0.7222 Intermediate Similarity NPD6696 Suspended
0.7219 Intermediate Similarity NPD1510 Phase 2
0.7218 Intermediate Similarity NPD968 Approved
0.7212 Intermediate Similarity NPD7229 Phase 3
0.7212 Intermediate Similarity NPD6071 Discontinued
0.7211 Intermediate Similarity NPD7095 Approved
0.7205 Intermediate Similarity NPD7819 Suspended
0.719 Intermediate Similarity NPD2424 Discontinued
0.7185 Intermediate Similarity NPD4750 Phase 3
0.7181 Intermediate Similarity NPD2238 Phase 2
0.7179 Intermediate Similarity NPD4357 Discontinued
0.7171 Intermediate Similarity NPD2796 Approved
0.7171 Intermediate Similarity NPD2161 Phase 2
0.7153 Intermediate Similarity NPD5327 Phase 3
0.7152 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6959 Discontinued
0.7151 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3060 Approved
0.7134 Intermediate Similarity NPD4123 Phase 3
0.7133 Intermediate Similarity NPD230 Phase 1
0.7114 Intermediate Similarity NPD6233 Phase 2
0.7113 Intermediate Similarity NPD6516 Phase 2
0.7113 Intermediate Similarity NPD5846 Approved
0.7108 Intermediate Similarity NPD3787 Discontinued
0.7105 Intermediate Similarity NPD7033 Discontinued
0.7101 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD2977 Approved
0.7099 Intermediate Similarity NPD5772 Approved
0.7099 Intermediate Similarity NPD1242 Phase 1
0.7099 Intermediate Similarity NPD2978 Approved
0.7099 Intermediate Similarity NPD5773 Approved
0.7097 Intermediate Similarity NPD4628 Phase 3
0.7089 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD6653 Approved
0.7083 Intermediate Similarity NPD1608 Approved
0.7078 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD1774 Approved
0.707 Intermediate Similarity NPD6799 Approved
0.7067 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD4140 Approved
0.7067 Intermediate Similarity NPD1240 Approved
0.7066 Intermediate Similarity NPD3926 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data